Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Ensysce Biosciences, Inc. (ENSC) had Receiveable Turnover of 22.86 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$2.23M |
|
$-10.63M |
|
-- |
|
$2.23M |
|
$12.95M |
|
$-10.72M |
|
$0.09M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.72M |
|
$-10.39M |
|
2.26M |
|
2.26M |
|
$-4.69 |
|
$-4.69 |
|
| Balance Sheet Financials | |
$2.29M |
|
-- |
|
$0.42M |
|
$2.71M |
|
$3.33M |
|
-- |
|
$0.03M |
|
$3.36M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
3.15M |
|
| Cash Flow Statement Financials | |
$-10.78M |
|
-- |
|
$8.76M |
|
$3.15M |
|
$1.12M |
|
$-2.02M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.69 |
|
-- |
|
-- |
|
-- |
|
-1.31 |
|
100.00% |
|
-480.52% |
|
-480.52% |
|
-465.90% |
|
-476.40% |
|
-476.39% |
|
$-10.78M |
|
-- |
|
-- |
|
-- |
|
0.82 |
|
-- |
|
|
Receiveable Turnover |
22.86 |
15.96 |
|
1631.62% |
|
1631.63% |
|
-392.39% |
|
1631.63% |
|
$-0.21 |
|
$-4.76 |
|
$-4.76 |
|